8-K - Amylyx Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1. The information in Item 7.01 of this Curren

Regulation Fd

8.01

Other Events On January 8, 2026, Amylyx Pharmaceuticals, Inc. (the “Company”) announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-1)

Other Event

$50.0M$4.0M

9.01

Financial Statements and Exhibits (d) Exhibits. Exhibit Number Description 99.1 Corporate Presentation, furnished herewith. 104 Cover Page Interactive Data File

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1